#EAU20 Virtual - Management of patients with CRPC in 2020

EAU
7/17/20, 8:00 PM
Europe/Madrid GMT+2

Description

Management of patients with CRPC in 2020

Thematic session 03

 

Fri 17 July

17:00 - 18:30

Location:Virtual room 1Chairs: M. De Santis, Berlin (DE)

M. Wirth, Dresden (DE)

 

Learning objectives

This session will review the current challenges in the management of castration resistant prostate cancer in view of novel imaging, novel therapeutics, earlier use of anticancer drugs, molecular markers and pathology. A focus will be prediction of response and sequencing of treatment options. Case based discussions will exemplify the challenges in 2020 for daily practice.

 

17:00 - 17:15

CRPC: Prediction of response to systemic treatment

L. Horvath, Sydney (AU)

17:15 - 17:30

Imaging of CRPC - what is possible, what is necessary?

W.L. Loidl, Linz (AT)

17:30 - 17:45

Molecular pathology before systemic treatment - what is feasible?

S. Perner, Luebeck (DE)

17:45 - 17:50

Discussion, questions and answers

M. De Santis, Berlin (DE)

M. Wirth, Dresden (DE)

17:50 - 18:15

Case-based debate M0 CRPC: Androgen Receptor Targeted Treatment (ARTA)

17:50 - 17:55

Case presentation

G. Gandaglia, Milan (IT)

17:55 - 18:05

Yes

A. Morgans, Chicago (US)

18:05 - 18:15

No

J. Bedke, Tübingen (DE)

18:15 - 18:25

The best sequence for M+ CRPC in 2020

A. Birtle, Preston (GB)

18:25 - 18:30

Discussion, questions and answers

M. De Santis, Berlin (DE)

M. Wirth, Dresden (DE)

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

M. De Santis, M. Wirth

CRPC: Prediction of response to systemic treatment

Inglês

 

Speakers

L. Horvath, W.L. Loidl, S. Perner, G. Gandaglia, A. Morgans, J. Bedke, A. Birtle

 

Link to the Event

Banner to the Event

#EAU20 Virtual - Management of patients with CRPC in 2020